Leyden Labs
Leyden Labs develops a portfolio of nasal sprays to provide protection against influenza, coronaviruses, and other respiratory viruses. Their Mucosal Protection Platform uses broadly protective intranasally administered antibodies. This approach offers a non-vaccine method for preventing respiratory viral infections.
Buy Funded Startups lists
Funding Round:
Funding Amount: $70M
Date: 09-Jan-2025
Investors: ClavystBio, Polaris Partners, Qiming Venture Partners, GV, Casdin Capital, F-Prime Capital, Invus, Byers Capital, Bluebird Ventures, Softbank Vision Fund 2
Markets: Biotechnology, Pharmaceuticals, Healthtech
HQ: Leiden, South Holland, Netherlands
Founded: 2020
Website: https://www.leydenlabs.com
LinkedIn: https://www.linkedin.com/company/leydenlabs/
Twitter: https://twitter.com/LeydenLabs
Crunchbase: https://www.crunchbase.com/organization/leyden-labs
Leave a Comment
Comments
No comments yet.